We genotyped three potentially functional polymorphisms in 635 MDD patients, 286 BD patients and 730 normal, control patients.
The genotype frequencies of SNP rs1051375 showed statistically significant differences between the BD and control groups (P=0.005). At the allele level, the difference of G allele frequency of rs1051375 between BD patients and control subjects was also significant (P=0.011; OR=1.30, 95 % CI: 1.06-1.58). We found that GG genotype of rs1051375 carriers had a lower age at onset than those with the AG or AA genotype, and the mean¡Àstandard deviation ages at onset of GG, AG and AA carriers were 24.04¡À4.22, 25.76¡À4.75 and 25.78¡À4.33 years, respectively. Neither genotype nor allele frequencies of the three polymorphisms were found to be significantly different between the MDD patients and control subjects.
The relative small sample size in BD group should be considered a limitation of this study.
Our initial findings support a potential association of CACNA1C as a genetic risk factor for BD susceptibility.